{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:32:50Z","timestamp":1791012770962,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T00:00:00Z","timestamp":1254873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/ejhg.2009.160","type":"journal-article","created":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T10:20:43Z","timestamp":1254910843000},"page":"146-153","source":"Crossref","is-referenced-by-count":36,"title":["Progress in therapeutic antisense applications for neuromuscular disorders"],"prefix":"10.1038","volume":"18","author":[{"given":"Annemieke","family":"Aartsma-Rus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert-Jan B","family":"van Ommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"key":"BFejhg2009160_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","volume":"359","author":"AE Emery","year":"2002","unstructured":"Emery AE : The muscular dystrophies. Lancet 2002; 359: 687\u2013695.","journal-title":"Lancet"},{"key":"BFejhg2009160_CR2","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nrg1180","volume":"4","author":"JC van Deutekom","year":"2003","unstructured":"van Deutekom JC, van Ommen GJ : Advances in Duchenne muscular dystrophy gene therapy. Nat Rev Genet 2003; 4: 774\u2013783.","journal-title":"Nat Rev Genet"},{"key":"BFejhg2009160_CR3","first-page":"184","volume":"24","author":"LM Judge","year":"2005","unstructured":"Judge LM, Chamberlain JS : Gene therapy for Duchenne muscular dystrophy: AAV leads the way. Acta Myol 2005; 24: 184\u2013193.","journal-title":"Acta Myol"},{"key":"BFejhg2009160_CR4","unstructured":"Antisense Drug Technology: Principles, Strategies, and Applications. New York: Marcel Dekker Inc., 2001."},{"key":"BFejhg2009160_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","volume":"82","author":"Y Hua","year":"2008","unstructured":"Hua Y, Vickers TA, Okunola HL, Bennett CF, Krainer AR : Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet 2008; 82: 834\u2013848.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2009160_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.molcel.2007.01.031","volume":"25","author":"J Krol","year":"2007","unstructured":"Krol J, Fiszer A, Mykowska A, Sobczak K, de Mezer M, Krzyzosiak WJ : Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol Cell 2007; 25: 575\u2013586.","journal-title":"Mol Cell"},{"key":"BFejhg2009160_CR7","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1056\/NEJMoa073108","volume":"357","author":"JC van Deutekom","year":"2007","unstructured":"van Deutekom JC, Janson AA, Ginjaar IB et al: Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 2007; 357: 2677\u20132686.","journal-title":"N Engl J Med"},{"key":"BFejhg2009160_CR8","first-page":"3952","volume":"117","author":"TM Wheeler","year":"2007","unstructured":"Wheeler TM, Lueck JD, Swanson MS, Dirksen RT, Thornton CA : Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J Clin Invest 2007; 117: 3952\u20133957.","journal-title":"J Clin Invest"},{"key":"BFejhg2009160_CR9","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1056\/NEJMe0707795","volume":"357","author":"EP Hoffman","year":"2007","unstructured":"Hoffman EP : Skipping toward personalized molecular medicine. N Engl J Med 2007; 357: 2719\u20132722.","journal-title":"N Engl J Med"},{"key":"BFejhg2009160_CR10","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1371\/journal.pbio.0050073","volume":"5","author":"Y Hua","year":"2007","unstructured":"Hua Y, Vickers TA, Baker BF, Bennett CF, Krainer AR : Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol 2007; 5: e73.","journal-title":"PLoS Biol"},{"key":"BFejhg2009160_CR11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown Jr RH, Kunkel LM : Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919\u2013928.","journal-title":"Cell"},{"key":"BFejhg2009160_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","volume":"2","author":"AP Monaco","year":"1988","unstructured":"Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM : An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988; 2: 90\u201395.","journal-title":"Genomics"},{"key":"BFejhg2009160_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/jnnp.2007.141721","volume":"80","author":"M Kohler","year":"2009","unstructured":"Kohler M, Clarenbach CF, Bahler C, Brack T, Russi EW, Bloch KE : Disability and survival in Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 2009; 80: 320\u2013325.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFejhg2009160_CR14","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mus.20812","volume":"36","author":"C Angelini","year":"2007","unstructured":"Angelini C : The role of corticosteroids in muscular dystrophy: a critical appraisal. Muscle Nerve 2007; 36: 424\u2013435.","journal-title":"Muscle Nerve"},{"key":"BFejhg2009160_CR15","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJM198805263182104","volume":"318","author":"EP Hoffman","year":"1988","unstructured":"Hoffman EP, Fischbeck KH, Brown RH et al: Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 1988; 318: 1363\u20131368.","journal-title":"N Engl J Med"},{"key":"BFejhg2009160_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/hmg\/ddg100","volume":"12","author":"A Aartsma-Rus","year":"2003","unstructured":"Aartsma-Rus A, Janson AA, Kaman WE et al: Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. Hum Mol Genet 2003; 12: 907\u2013914.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2009160_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1086\/381039","volume":"74","author":"A Aartsma-Rus","year":"2004","unstructured":"Aartsma-Rus A, Janson AA, Kaman WE et al: Antisense-induced multiexon skipping for duchenne muscular dystrophy makes more sense. Am J Hum Genet 2004; 74: 83\u201392.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2009160_CR18","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0387-7604(01)00326-6","volume":"23","author":"Y Takeshima","year":"2001","unstructured":"Takeshima Y, Wada H, Yagi M et al: Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient. Brain Dev 2001; 23: 788\u2013790.","journal-title":"Brain Dev"},{"key":"BFejhg2009160_CR19","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/hmg\/10.15.1547","volume":"10","author":"JC van Deutekom","year":"2001","unstructured":"van Deutekom JC, Bremmer-Bout M, Janson AA et al: Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum Mol Genet 2001; 10: 1547\u20131554.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2009160_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/humu.20918","volume":"30","author":"A Aartsma-Rus","year":"2009","unstructured":"Aartsma-Rus A, Fokkema IF, Verschuuren JJ et al: Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Hum Mutat 2009; 30: 293\u2013299.","journal-title":"Hum Mutat"},{"key":"BFejhg2009160_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/1043034041648444","volume":"15","author":"A Surono","year":"2004","unstructured":"Surono A, Van Khanh T, Takeshima Y et al: Chimeric RNA\/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of Duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon. Hum Gene Ther 2004; 15: 749\u2013757.","journal-title":"Hum Gene Ther"},{"key":"BFejhg2009160_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/jgm.1265","volume":"11","author":"C Mitrpant","year":"2009","unstructured":"Mitrpant C, Fletcher S, Iversen PL, Wilton SD : By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping. J Gene Med 2009; 11: 46\u201356.","journal-title":"J Gene Med"},{"key":"BFejhg2009160_CR23","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nm897","volume":"8","author":"QL Lu","year":"2003","unstructured":"Lu QL, Mann CJ, Lou F et al: Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nat Med 2003; 8: 1009\u20131014.","journal-title":"Nat Med"},{"key":"BFejhg2009160_CR24","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/sj.gt.3302800","volume":"13","author":"G McClorey","year":"2006","unstructured":"McClorey G, Moulton HM, Iversen PL, Fletcher S, Wilton SD : Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Therapy 2006; 13: 1373\u20131381.","journal-title":"Gene Therapy"},{"key":"BFejhg2009160_CR25","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1517\/14712598.7.6.831","volume":"7","author":"T Yokota","year":"2007","unstructured":"Yokota T, Pistilli E, Duddy W, Nagaraju K : Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy. Expert Opin Biol Ther 2007; 7: 831\u2013842.","journal-title":"Expert Opin Biol Ther"},{"key":"BFejhg2009160_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ana.21290","volume":"63","author":"OL Gurvich","year":"2008","unstructured":"Gurvich OL, Tuohy TM, Howard MT et al: DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy. Ann Neurol 2008; 63: 81\u201389.","journal-title":"Ann Neurol"},{"key":"BFejhg2009160_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20806","volume":"30","author":"HR Madden","year":"2009","unstructured":"Madden HR, Fletcher S, Davis MR, Wilton SD : Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping. Hum Mutat 2009; 30: 22\u201328.","journal-title":"Hum Mutat"},{"key":"BFejhg2009160_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mus.20586","volume":"34","author":"A Aartsma-Rus","year":"2006","unstructured":"Aartsma-Rus A, van Deutekom JC, Fokkema IF, van Ommen GJ, den Dunnen JT : Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve 2006; 34: 135\u2013144.","journal-title":"Muscle Nerve"},{"key":"BFejhg2009160_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2350-8-43","volume":"8","author":"A Aartsma-Rus","year":"2007","unstructured":"Aartsma-Rus A, Janson AA, van Ommen GJ, van Deutekom JC : Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy. BMC Med Genet 2007; 8: 43.","journal-title":"BMC Med Genet"},{"key":"BFejhg2009160_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4103\/0028-3886.43443","volume":"56","author":"SD Wilton","year":"2008","unstructured":"Wilton SD, Fletcher S : Exon skipping and Duchenne muscular dystrophy: hope, hype and how feasible? Neurol India 2008; 56: 254\u2013262.","journal-title":"Neurol India"},{"key":"BFejhg2009160_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/oli.2005.15.284","volume":"15","author":"A Aartsma-Rus","year":"2005","unstructured":"Aartsma-Rus A, Winter CL, Janson AAM et al: Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sites. Oligonucleotides 2005; 15: 284\u2013297.","journal-title":"Oligonucleotides"},{"key":"BFejhg2009160_CR32","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/sj.mt.6300095","volume":"15","author":"SD Wilton","year":"2007","unstructured":"Wilton SD, Fall AM, Harding PL, McClorey G, Coleman C, Fletcher S : Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript. Mol Ther 2007; 15: 1288\u20131296.","journal-title":"Mol Ther"},{"key":"BFejhg2009160_CR33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.nmd.2007.11.010","volume":"18","author":"F Muntoni","year":"2008","unstructured":"Muntoni F, Bushby KD, van Ommen G : 149th ENMC International Workshop and 1st TREAT-NMD Workshop on: \u2018planning phase i\/ii clinical trials using systemically delivered antisense oligonucleotides in duchenne muscular dystrophy\u2019. Neuromuscul Disord 2008; 18: 268\u2013275.","journal-title":"Neuromuscul Disord"},{"key":"BFejhg2009160_CR34","volume-title":"Antisense Elements (Genetics) Research Focus","author":"A Aartsma-Rus","year":"2007","unstructured":"Aartsma-Rus A, van Deutekom JC : Antisense-mediated reading-frame restoration as a genetic therapy for duchenne muscular dystrophy; in Hernandes AG (ed): Antisense Elements (Genetics) Research Focus. Nova publishers: Hauppauge, NY, USA, 2007."},{"key":"BFejhg2009160_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm1345","volume":"12","author":"J Alter","year":"2006","unstructured":"Alter J, Lou F, Rabinowitz A . et al: Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat Med 2006; 12: 175\u2013177.","journal-title":"Nat Med"},{"key":"BFejhg2009160_CR36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1073\/pnas.0406700102","volume":"102","author":"QL Lu","year":"2005","unstructured":"Lu QL, Rabinowitz A, Chen YC et al: Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc Natl Acad Sci USA 2005; 102: 198\u2013203.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2009160_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/jgm.1288","volume":"11","author":"HA Heemskerk","year":"2009","unstructured":"Heemskerk HA, De Winter CL, de Kimpe SJ et al: In vivo comparison of 2\u2032-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping. J Gene Med 2009; 11: 257\u2013266.","journal-title":"J Gene Med"},{"key":"BFejhg2009160_CR38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.nmd.2008.05.011","volume":"18","author":"L Vitiello","year":"2008","unstructured":"Vitiello L, Bassi N, Campagnolo P et al: In vivo delivery of naked antisense oligos in aged mdx mice: analysis of dystrophin restoration in skeletal and cardiac muscle. Neuromuscul Disord 2008; 18: 597\u2013605.","journal-title":"Neuromuscul Disord"},{"key":"BFejhg2009160_CR39","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/sj.mt.6300245","volume":"15","author":"S Fletcher","year":"2007","unstructured":"Fletcher S, Honeyman K, Fall AM et al: Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse. Mol Ther 2007; 15: 1587\u20131592.","journal-title":"Mol Ther"},{"key":"BFejhg2009160_CR40","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1093\/hmg\/ddn293","volume":"17","author":"H Yin","year":"2008","unstructured":"Yin H, Moulton HM, Seow Y et al: Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function. Hum Mol Genet 2008; 17: 3909\u20133918.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2009160_CR41","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/mt.2008.120","volume":"16","author":"N Jearawiriyapaisarn","year":"2008","unstructured":"Jearawiriyapaisarn N, Moulton HM, Buckley B et al: Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. Mol Ther 2008; 16: 1624\u20131629.","journal-title":"Mol Ther"},{"key":"BFejhg2009160_CR42","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1126\/science.1104297","volume":"306","author":"A Goyenvalle","year":"2004","unstructured":"Goyenvalle A, Vulin A, Fougerousse F et al: Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 2004; 306: 1796\u20131799.","journal-title":"Science"},{"key":"BFejhg2009160_CR43","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1073\/pnas.0508917103","volume":"103","author":"MA Denti","year":"2006","unstructured":"Denti MA, Rosa A, D'Antona G et al: Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model. Proc Natl Acad Sci USA 2006; 103: 3758\u20133763.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2009160_CR44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/hum.2008.012","volume":"19","author":"MA Denti","year":"2008","unstructured":"Denti MA, Incitti T, Sthandier O et al: Long-term benefit of adeno-associated virus\/antisense-mediated exon skipping in dystrophic mice. Hum Gene Ther 2008; 19: 601\u2013608.","journal-title":"Hum Gene Ther"},{"key":"BFejhg2009160_CR45","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/sj.gt.3302984","volume":"14","author":"K Yuasa","year":"2007","unstructured":"Yuasa K, Yoshimura M, Urasawa N et al: Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Gene Therapy 2007; 14: 1249\u20131260.","journal-title":"Gene Therapy"},{"key":"BFejhg2009160_CR46","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/gt.2008.54","volume":"15","author":"AK Zaiss","year":"2008","unstructured":"Zaiss AK, Muruve DA : Immunity to adeno-associated virus vectors in animals and humans: a continued challenge. Gene Therapy 2008; 15: 808\u2013816.","journal-title":"Gene Therapy"},{"key":"BFejhg2009160_CR47","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/gt.2008.65","volume":"15","author":"JF Wright","year":"2008","unstructured":"Wright JF : Manufacturing and characterizing AAV-based vectors for use in clinical studies. Gene Therapy 2008; 15: 840\u2013848.","journal-title":"Gene Therapy"},{"key":"BFejhg2009160_CR48","first-page":"140","volume":"10","author":"GJ van Ommen","year":"2008","unstructured":"van Ommen GJ, van Deutekom J, Aartsma-Rus A : The therapeutic potential of antisense-mediated exon skipping. Curr Opin Mol Ther 2008; 10: 140\u2013149.","journal-title":"Curr Opin Mol Ther"},{"key":"BFejhg2009160_CR49","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0959-437X(02)00301-5","volume":"12","author":"T Frugier","year":"2002","unstructured":"Frugier T, Nicole S, Cifuentes-Diaz C, Melki J : The molecular bases of spinal muscular atrophy. Curr Opin Genet Dev 2002; 12: 294\u2013298.","journal-title":"Curr Opin Genet Dev"},{"key":"BFejhg2009160_CR50","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S et al: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155\u2013165.","journal-title":"Cell"},{"key":"BFejhg2009160_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrm760","volume":"3","author":"G Dreyfuss","year":"2002","unstructured":"Dreyfuss G, Kim VN, Kataoka N : Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 2002; 3: 195\u2013205.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFejhg2009160_CR52","doi-asserted-by":"publisher","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","volume":"94","author":"B Schrank","year":"1997","unstructured":"Schrank B, Gotz R, Gunnersen JM et al: Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci USA 1997; 94: 9920\u20139925.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2009160_CR53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ng0598-63","volume":"19","author":"CL Lorson","year":"1998","unstructured":"Lorson CL, Strasswimmer J, Yao JM et al: SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet 1998; 19: 63\u201366.","journal-title":"Nat Genet"},{"key":"BFejhg2009160_CR54","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, Hahnen E, Androphy EJ, Wirth B : A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 1999; 96: 6307\u20136311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2009160_CR55","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW et al: A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 1999; 8: 1177\u20131183.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2009160_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/00125817-200201000-00004","volume":"4","author":"MD Mailman","year":"2002","unstructured":"Mailman MD, Heinz JW, Papp AC et al: Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med 2002; 4: 20\u201326.","journal-title":"Genet Med"},{"key":"BFejhg2009160_CR57","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1073\/pnas.171105098","volume":"98","author":"JG Chang","year":"2001","unstructured":"Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H : Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 2001; 98: 9808\u20139813.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2009160_CR58","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/sj.gt.3301550","volume":"8","author":"ML Zhang","year":"2001","unstructured":"Zhang ML, Lorson CL, Androphy EJ, Zhou J : An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Therapy 2001; 8: 1532\u20131538.","journal-title":"Gene Therapy"},{"key":"BFejhg2009160_CR59","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/hmg\/10.24.2841","volume":"10","author":"C Andreassi","year":"2001","unstructured":"Andreassi C, Jarecki J, Zhou J et al: Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet 2001; 10: 2841\u20132849.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2009160_CR60","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ana.10743","volume":"54","author":"CJ Sumner","year":"2003","unstructured":"Sumner CJ, Huynh TN, Markowitz JA et al: Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 2003; 54: 647\u2013654.","journal-title":"Ann Neurol"},{"key":"BFejhg2009160_CR61","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng854","volume":"30","author":"L Cartegni","year":"2002","unstructured":"Cartegni L, Krainer AR : Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 2002; 30: 377\u2013384.","journal-title":"Nat Genet"},{"key":"BFejhg2009160_CR62","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ng1207","volume":"34","author":"T Kashima","year":"2003","unstructured":"Kashima T, Manley JL : A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 2003; 34: 460\u2013463.","journal-title":"Nat Genet"},{"key":"BFejhg2009160_CR63","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1073\/pnas.0700343104","volume":"104","author":"T Kashima","year":"2007","unstructured":"Kashima T, Rao N, Manley JL : An intronic element contributes to splicing repression in spinal muscular atrophy. Proc Natl Acad Sci USA 2007; 104: 3426\u20133431.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2009160_CR64","doi-asserted-by":"publisher","first-page":"15825","DOI":"10.1074\/jbc.M209271200","volume":"278","author":"H Miyaso","year":"2003","unstructured":"Miyaso H, Okumura M, Kondo S, Higashide S, Miyajima H, Imaizumi K : An intronic splicing enhancer element in survival motor neuron (SMN) pre-mRNA. J Biol Chem 2003; 278: 15825\u201315831.","journal-title":"J Biol Chem"},{"key":"BFejhg2009160_CR65","doi-asserted-by":"publisher","first-page":"23271","DOI":"10.1074\/jbc.M200851200","volume":"277","author":"H Miyajima","year":"2002","unstructured":"Miyajima H, Miyaso H, Okumura M, Kurisu J, Imaizumi K : Identification of a cis-acting element for the regulation of SMN exon 7 splicing. J Biol Chem 2002; 277: 23271\u201323277.","journal-title":"J Biol Chem"},{"key":"BFejhg2009160_CR66","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1261\/rna.7580704","volume":"10","author":"NN Singh","year":"2004","unstructured":"Singh NN, Androphy EJ, Singh RN : In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes. RNA 2004; 10: 1291\u20131305.","journal-title":"RNA"},{"key":"BFejhg2009160_CR67","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bbrc.2004.01.067","volume":"315","author":"NN Singh","year":"2004","unstructured":"Singh NN, Androphy EJ, Singh RN : An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy. Biochem Biophys Res Commun 2004; 315: 381\u2013388.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFejhg2009160_CR68","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4161\/rna.4.1.4535","volume":"4","author":"RN Singh","year":"2007","unstructured":"Singh RN : Evolving concepts on human SMN pre-mRNA splicing. RNA Biol 2007; 4: 7\u201310.","journal-title":"RNA Biol"},{"key":"BFejhg2009160_CR69","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","volume":"26","author":"NK Singh","year":"2006","unstructured":"Singh NK, Singh NN, Androphy EJ, Singh RN : Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol 2006; 26: 1333\u20131346.","journal-title":"Mol Cell Biol"},{"key":"BFejhg2009160_CR70","doi-asserted-by":"publisher","first-page":"45476","DOI":"10.1074\/jbc.M107632200","volume":"276","author":"SR Lim","year":"2001","unstructured":"Lim SR, Hertel KJ : Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3\u2032 splice site pairing. J Biol Chem 2001; 276: 45476\u201345483.","journal-title":"J Biol Chem"},{"key":"BFejhg2009160_CR71","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ymthe.2005.08.022","volume":"12","author":"C Madocsai","year":"2005","unstructured":"Madocsai C, Lim SR, Geib T, Lam BJ, Hertel KJ : Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs. Mol Ther 2005; 12: 1013\u20131022.","journal-title":"Mol Ther"},{"key":"BFejhg2009160_CR72","doi-asserted-by":"crossref","unstructured":"Dickson A, Osman E, Lorson C : A Negatively-Acting Bifunctional RNA Increases Survival Motor Neuron in vitro and in vivo. Hum Gene Ther 2008; 25 August [e-pub ahead of print].","DOI":"10.1089\/hgt.2008.067"},{"key":"BFejhg2009160_CR73","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nsb887","volume":"10","author":"L Cartegni","year":"2003","unstructured":"Cartegni L, Krainer AR : Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat Struct Biol 2003; 10: 120\u2013125.","journal-title":"Nat Struct Biol"},{"key":"BFejhg2009160_CR74","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1073\/pnas.0633863100","volume":"100","author":"LA Skordis","year":"2003","unstructured":"Skordis LA, Dunckley MG, Yue B, Eperon IC, Muntoni F : Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc Natl Acad Sci USA 2003; 100: 4114\u20134119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2009160_CR75","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymthe.2006.01.012","volume":"14","author":"T Baughan","year":"2006","unstructured":"Baughan T, Shababi M, Coady TH, Dickson AM, Tullis GE, Lorson CL : Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector. Mol Ther 2006; 14: 54\u201362.","journal-title":"Mol Ther"},{"key":"BFejhg2009160_CR76","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/sj.mt.6300200","volume":"15","author":"J Marquis","year":"2007","unstructured":"Marquis J, Meyer K, Angehrn L, Kampfer SS, Rothen-Rutishauser B, Schumperli D : Spinal Muscular Atrophy: SMN2 Pre-mRNA Splicing Corrected by a U7 snRNA Derivative Carrying a Splicing Enhancer Sequence. Mol Ther 2007; 15: 1479\u20131486.","journal-title":"Mol Ther"},{"key":"BFejhg2009160_CR77","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/gt.2008.138","volume":"16","author":"J Marquis","year":"2009","unstructured":"Marquis J, Kampfer SS, Angehrn L, Schumperli D : Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes. Gene Therapy 2009; 16: 70\u201377.","journal-title":"Gene Therapy"},{"key":"BFejhg2009160_CR78","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/hmg\/ddn382","volume":"18","author":"K Meyer","year":"2009","unstructured":"Meyer K, Marquis J, Trub J et al: Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation. Hum Mol Genet 2009; 18: 546\u2013555.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2009160_CR79","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1126\/science.1589758","volume":"256","author":"CT Caskey","year":"1992","unstructured":"Caskey CT, Pizzuti A, Fu YH, Fenwick Jr RG, Nelson DL : Triplet repeat mutations in human disease. Science 1992; 256: 784\u2013789.","journal-title":"Science"},{"key":"BFejhg2009160_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mus.20301","volume":"32","author":"L Machuca-Tzili","year":"2005","unstructured":"Machuca-Tzili L, Brook D, Hilton-Jones D : Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 2005; 32: 1\u201318.","journal-title":"Muscle Nerve"},{"key":"BFejhg2009160_CR81","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1062125","volume":"293","author":"CL Liquori","year":"2001","unstructured":"Liquori CL, Ricker K, Moseley ML et al: Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001; 293: 864\u2013867.","journal-title":"Science"},{"key":"BFejhg2009160_CR82","first-page":"385","volume":"69","author":"JD Brook","year":"1992","unstructured":"Brook JD, McCurrach ME, Harley HG et al: Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member. Cell 1992; 69: 385.","journal-title":"Cell"},{"key":"BFejhg2009160_CR83","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bbadis.2006.05.013","volume":"1772","author":"DH Cho","year":"2007","unstructured":"Cho DH, Tapscott SJ : Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 2007; 1772: 195\u2013204.","journal-title":"Biochim Biophys Acta"},{"key":"BFejhg2009160_CR84","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1083\/jcb.128.6.995","volume":"128","author":"KL Taneja","year":"1995","unstructured":"Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH : Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 1995; 128: 995\u20131002.","journal-title":"J Cell Biol"},{"key":"BFejhg2009160_CR85","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/hmg\/11.7.805","volume":"11","author":"M Fardaei","year":"2002","unstructured":"Fardaei M, Rogers MT, Thorpe HM et al: Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 2002; 11: 805\u2013814.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2009160_CR86","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1126\/science.280.5364.737","volume":"280","author":"AV Philips","year":"1998","unstructured":"Philips AV, Timchenko LT, Cooper TA : Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998; 280: 737\u2013741.","journal-title":"Science"},{"key":"BFejhg2009160_CR87","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/ejhg.2008.227","volume":"17","author":"RP Junghans","year":"2009","unstructured":"Junghans RP : Dystrophia myotonia: why focus on foci? Eur J Hum Genet 2009; 17: 543\u2013553.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2009160_CR88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1097-2765(02)00572-5","volume":"10","author":"B Charlet","year":"2002","unstructured":"Charlet B, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA : Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002; 10: 45\u201353.","journal-title":"Mol Cell"},{"key":"BFejhg2009160_CR89","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1086\/421528","volume":"74","author":"RS Savkur","year":"2004","unstructured":"Savkur RS, Philips AV, Cooper TA et al: Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 2004; 74: 1309\u20131313.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2009160_CR90","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","volume":"10","author":"A Mankodi","year":"2002","unstructured":"Mankodi A, Takahashi MP, Jiang H et al: Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 2002; 10: 35\u201344.","journal-title":"Mol Cell"},{"key":"BFejhg2009160_CR91","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1126\/science.1088583","volume":"302","author":"RN Kanadia","year":"2003","unstructured":"Kanadia RN, Johnstone KA, Mankodi A et al: A muscleblind knockout model for myotonic dystrophy. Science 2003; 302: 1978\u20131980.","journal-title":"Science"},{"key":"BFejhg2009160_CR92","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1085\/jgp.200609635","volume":"129","author":"JD Lueck","year":"2007","unstructured":"Lueck JD, Mankodi A, Swanson MS, Thornton CA, Dirksen RT : Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy. J Gen Physiol 2007; 129: 79\u201394.","journal-title":"J Gen Physiol"},{"key":"BFejhg2009160_CR93","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1006\/bbrc.1996.0668","volume":"221","author":"U Galderisi","year":"1996","unstructured":"Galderisi U, Cipollaro M, Melone MA et al: Myotonic dystrophy: antisense oligonucleotide inhibition of DMPK gene expression in vitro. Biochem Biophys Res Commun 1996; 221: 750\u2013754.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFejhg2009160_CR94","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1126\/science.1173110","volume":"325","author":"TM Wheeler","year":"2009","unstructured":"Wheeler TM, Sobczak K, Lueck JD et al: Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 2009; 325: 336\u2013339.","journal-title":"Science"},{"key":"BFejhg2009160_CR95","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jama.280.10.871-JMN0909-6-1","volume":"280","author":"C Marwick","year":"1998","unstructured":"Marwick C : First \u2018antisense\u2019 drug will treat CMV retinitis. JAMA 1998; 280: 871.","journal-title":"JAMA"},{"key":"BFejhg2009160_CR96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jcb.20790","volume":"98","author":"WH Pan","year":"2006","unstructured":"Pan WH, Clawson GA : Antisense applications for biological control. J Cell Biochem 2006; 98: 14\u201335.","journal-title":"J Cell Biochem"},{"key":"BFejhg2009160_CR97","first-page":"10","volume":"10","author":"A Dorn","year":"2008","unstructured":"Dorn A, Kippenberger S : Clinical application of CpG-, non-CpG-, and antisense oligodeoxynucleotides as immunomodulators. Curr Opin Mol Ther 2008; 10: 10\u201320.","journal-title":"Curr Opin Mol Ther"},{"key":"BFejhg2009160_CR98","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.drudis.2008.03.014","volume":"13","author":"ER Rayburn","year":"2008","unstructured":"Rayburn ER, Zhang R : Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible? Drug Discov Today 2008; 13: 513\u2013521.","journal-title":"Drug Discov Today"},{"key":"BFejhg2009160_CR99","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/79951","volume":"26","author":"A Nasevicius","year":"2000","unstructured":"Nasevicius A, Ekker SC : Effective targeted gene \u2018knockdown\u2019 in zebrafish. Nat Genet 2000; 26: 216\u2013220.","journal-title":"Nat Genet"},{"key":"BFejhg2009160_CR100","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2741\/2697","volume":"13","author":"C Bertoni","year":"2008","unstructured":"Bertoni C : Clinical approaches in the treatment of Duchenne muscular dystrophy (DMD) using oligonucleotides. Front Biosci 2008; 13: 517\u2013527.","journal-title":"Front Biosci"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2009160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2009160","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2009160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:57:59Z","timestamp":1684429079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2009160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["BFejhg2009160"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2009.160","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,7]]}}}